News | October 12, 2021
Skanray to raise Rs 400 crore to fund its inorganic growth
Since its inception, the company has either acquired or taken a majority stake in five companies
Since its inception, the company has either acquired or taken a majority stake in five companies
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
A total of 8308 stores are open across India and medicines are priced at affordable rates
The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)
Torrent is one of India's fastest-growing pharma majors
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
The investment will increase SpeeDx internal capacity to scale up manufacturing
The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
Subscribe To Our Newsletter & Stay Updated
